Guggenheim Capital LLC Global Blood Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $911,379 - $1.92 Million	28,129 New	28,129 $1.92 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $1.06 Million - $1.72 Million	-42,692 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $131,731 - $193,047	5,170 Added 13.78%	42,692 $1.09 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $55,117 - $73,727	1,698 Added 4.74%	37,522 $1.31 Million
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $131,383 - $171,567	-3,374 Reduced 8.61%	35,824 $1.46 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $137,121 - $232,250	-3,642 Reduced 8.5%	39,198 $1.7 Million
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $383,776 - $541,840	-7,274 Reduced 14.51%	42,840 $2.36 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $559,469 - $939,375	11,481 Added 29.72%	50,114 $3.16 Million
Q1 2020 Jun 02, 2020	SELL	$41.72 - $87.2 $353,952 - $739,804	-8,484 Reduced 18.01%	38,633 $1.97 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $12,704 - $22,757	278 Added 0.59%	47,117 $3.75 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $1,950 - $2,490	43 Added 0.09%	46,839 $2.27 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $594,853 - $715,746	-11,309 Reduced 19.46%	46,796 $2.46 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $214,466 - $286,813	-5,363 Reduced 8.45%	58,105 $3.08 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $82,287 - $121,762	-2,609 Reduced 3.95%	63,468 $2.61 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $95,228 - $128,056	2,506 Added 3.94%	66,077 $2.51 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $265,095 - $343,527	6,850 Added 12.08%	63,571 $2.87 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $74,368 - $123,760	-1,878 Reduced 3.2%	56,721 $2.74 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $1.3 Million - $2.01 Million	-43,886 Reduced 42.82%	58,599 $2.31 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $2.57 Million - $3.18 Million	102,485	102,485 $3.18 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account